Differences in glucose, HbA1c, insulin, and HOMA between control subjects and T2D patients remained significant after subdivided by haplogroup (p < 0.001 for glucose, HbA1c, and HOMA when comparing control vs T2D belonging to haplogroups HV, JT, U, and Others. The gene discussed is INS; the disease is type 2 diabetes mellitus.